Health Care: Drugs

Cytori Therapeutics Inc (CYTX: NASDAQ)

$1.54 n/a | n/a%
12/02/16 - 03:59 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 11.66M 7.60M 12.20M 14.50M
Cost of Sales 749.00K 362.00K 694.00K 2.14M
Gross Operating Profit 10.91M 7.24M 11.50M 12.36M
Selling, General, and Administrative Expenses 12.43M 22.36M 25.06M 25.16M
Research & Development 19.00M 15.11M 17.07M 13.63M
Operating Income before D & A (EBITDA) -20.52M -30.23M -30.62M -26.42M
Depreciation & Amortization 2.44M 2.58M 2.73M 1.86M
Interest Income 9.00K 6.00K 4.00K 4.00K
Other Income - Net -88.00K -566.00K 3.05M -314.00K
Special Income / Charges 7.67M 369.00K 2.67M -131.00K
Total Income Before Interest Expenses (EBIT) -15.37M -33.00M -22.78M -28.89M
Interest Expense 3.38M 4.37M 3.40M 3.39M
Pre-Tax Income -18.74M -37.37M -26.18M -32.28M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -18.74M -37.37M -26.18M -32.28M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -18.74M -37.37M -26.18M -32.28M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -18.74M -37.37M -26.18M -32.28M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-26.41M -37.74M -28.84M -32.15M
Preferred Dividends
Net Income Available To Common -19.41M -38.54M -26.18M -32.28M
Basic EPS from Continuing Ops. -2.10 -7.20 -5.85 -8.25
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -2.10 -7.20 -5.85 -8.25
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -2.10 -7.20 -5.85 -8.25
Basic Normalized Net Income/Share -2.96 -7.27 -6.45 -8.22
EPS fr Continuing Ops. -2.10 -7.20 -5.85 -8.25
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -2.10 -7.20 -5.85 -8.25
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -2.10 -7.20 -5.85 -8.25
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.96 -7.27 -6.45 -8.22
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CYTX

Latest CYTX Headlines from TheStreet

More Financial News for CYTX

Press Releases for CYTX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter